ERBA, PAOLA ANNA
 Distribuzione geografica
Continente #
NA - Nord America 16.100
AS - Asia 8.138
EU - Europa 6.183
SA - Sud America 1.632
AF - Africa 311
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 32.393
Nazione #
US - Stati Uniti d'America 15.651
SG - Singapore 2.297
CN - Cina 2.157
IT - Italia 2.020
HK - Hong Kong 1.493
BR - Brasile 1.318
SE - Svezia 1.033
VN - Vietnam 855
DE - Germania 674
BG - Bulgaria 525
GB - Regno Unito 421
CA - Canada 324
FR - Francia 290
TR - Turchia 274
FI - Finlandia 244
RU - Federazione Russa 243
UA - Ucraina 212
IN - India 198
KR - Corea 162
JP - Giappone 144
AT - Austria 105
AR - Argentina 103
CH - Svizzera 95
BD - Bangladesh 93
NL - Olanda 89
CI - Costa d'Avorio 83
ID - Indonesia 72
MX - Messico 63
EC - Ecuador 60
IQ - Iraq 54
ZA - Sudafrica 52
SA - Arabia Saudita 46
UZ - Uzbekistan 40
PL - Polonia 38
TH - Thailandia 37
ES - Italia 35
CO - Colombia 34
SN - Senegal 34
PK - Pakistan 33
BE - Belgio 31
CL - Cile 29
MA - Marocco 28
VE - Venezuela 28
IR - Iran 27
PY - Paraguay 26
CZ - Repubblica Ceca 18
NG - Nigeria 18
DZ - Algeria 17
EG - Egitto 16
IE - Irlanda 16
IL - Israele 16
KE - Kenya 16
UY - Uruguay 16
AU - Australia 15
PH - Filippine 15
JO - Giordania 13
MY - Malesia 13
JM - Giamaica 12
TN - Tunisia 12
LT - Lituania 11
PE - Perù 11
PT - Portogallo 11
CR - Costa Rica 10
NP - Nepal 10
TW - Taiwan 10
BJ - Benin 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 8
GH - Ghana 8
GR - Grecia 8
HU - Ungheria 8
KZ - Kazakistan 8
DK - Danimarca 7
EU - Europa 7
KW - Kuwait 7
LB - Libano 7
LK - Sri Lanka 7
RO - Romania 7
AL - Albania 6
DO - Repubblica Dominicana 6
OM - Oman 6
AM - Armenia 5
AZ - Azerbaigian 5
BO - Bolivia 5
BY - Bielorussia 5
RS - Serbia 5
AF - Afghanistan, Repubblica islamica di 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
Totale 32.347
Città #
Ashburn 1.627
Hong Kong 1.476
Woodbridge 1.376
Fairfield 1.318
Singapore 1.272
Dallas 1.261
Houston 1.001
Ann Arbor 917
Chandler 742
San Jose 723
Santa Clara 663
Milan 600
Seattle 539
Shanghai 538
Sofia 523
Wilmington 469
Cambridge 425
New York 386
Beijing 360
Princeton 300
Jacksonville 278
Boardman 255
Ottawa 226
Lawrence 214
Los Angeles 212
Ho Chi Minh City 210
Hefei 190
Lauterbourg 187
Medford 174
London 173
Seoul 153
Bremen 139
Hanoi 138
Nanjing 137
Serra 135
Council Bluffs 134
Izmir 130
Tokyo 129
Des Moines 115
Dong Ket 114
Dearborn 104
São Paulo 103
Istanbul 94
Munich 93
Pisa 92
Buffalo 86
Vienna 85
Abidjan 83
Redondo Beach 81
Bern 75
Florence 75
San Diego 68
Rome 66
Redwood City 62
Helsinki 58
Nanchang 58
Frankfurt am Main 57
Jüchen 52
Chicago 45
Rio de Janeiro 45
Hebei 43
Columbus 41
Turku 40
Ogden 39
The Dalles 39
Nuremberg 38
Fuzhou 37
Kunming 36
Dakar 34
Shenyang 34
Belo Horizonte 32
Tashkent 32
Orem 31
Boulder 30
Düsseldorf 30
Johannesburg 30
Warsaw 30
Chennai 29
Brussels 26
Changsha 26
Guangzhou 26
Montreal 26
Quanzhou 26
Baghdad 25
Da Nang 25
Haiphong 25
Norwalk 24
Lancaster 23
Curitiba 22
Pune 22
Toronto 22
Bangkok 21
Dhaka 21
Brasília 20
Denver 20
Guayaquil 20
Jiaxing 19
Paris 19
Zurich 19
Campinas 18
Totale 22.561
Nome #
Diagnostic applications of nuclear medicine: Multiple myeloma 759
International Impact of COVID-19 on the Diagnosis of Heart Disease 452
Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 348
Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) 320
[F-18]FMCH intratumor heterogeneity analysis by advanced texture analysis in patients with prostate cancer recurrence 279
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: Preliminary results 241
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World 237
Nuclear medicine imaging of bone infections 236
New approaches for imaging and therapy of solid cancer 232
Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. 228
Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents 224
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 222
Antioxidants: a tale of two stories. 221
Detecting the vulnerable carotid plaque: the Carotid Artery Multimodality imaging Prognostic study design 218
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology 214
Towards the use of nanoparticles in cancer therapy and imaging 213
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 211
Design and fabrication of novel polymeric biodegradable stents for small caliber blood vessels by computer-aided wet-spinning 207
Clinical Applications of Nuclear Medicine: Multiple Myeloma 203
pH-responsive carboxymethylcellulose nanoparticles for 68Ga-WBC labeling in PET imaging 203
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 202
Diagnostic Applications of Nuclear Medicine: Leukemias 193
Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings 191
Combination of DWI/DCE-MRI and [18F]FECH PET/CT in Patients with Biochemical Relapse of Prostate Cancer: Impact on Treatment Decision Making, EANM’14, Annual Congress of the European Association of Nuclear Medicine 187
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 186
Body composition and metabolic profile in women with complete androgen insensitivity syndrome. 186
Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006 185
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies. 183
Dosimetry for nonuniform activity distributions: a method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations. 181
An Improved Protocol for Increasing the Potential of Lymphoscintigraphy in patients with Peripheral Lymphedema 180
Usefulness of phalangeal quantitative ultrasound in identifying reduced bone mineral status and increased fracture risk in adolescents with Turner syndrome. 180
18F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 180
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. 179
Radionuclide Evaluation of Gaucher Disease 179
Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes 179
Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism 176
Improving women's health in low-income and middle-income countries. Part II: The needs of diagnostic imaging 176
Clinical feasibility of two-step Streptavidin/111In-Biotin scintigraphy in patients with suspected vertebral osteomyelitis 174
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial 174
CERENKOV LUMINESCENCE IMAGING IN PULMONARY AND HEPATIC METASTASECTOMY 174
Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective 173
Comparison of [18F]FDG PET/CT and 99mTc-HMPAO-labeled leukocyte (99mTc-HMPAO-WBC) SPECT/CT in patients with cardiovascular device infection. Eanm'14 172
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 171
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 170
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 170
Fraibility of Bone Marrow Scintigraphy with 99mTc-Sestamibi in the evaluation of Patients with Multiple Mieloma: Initial one-Center Experience 169
Homing of (111)ln-oxine radiolabelled endothelial progenitor cells in ischemic or inflammed mice hindlimbs: Differential cytokine and chemokine profile 169
Radionuclide Therapy of Leukemias 168
Radiotracers for fungal infection imaging 167
Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents 166
Pathophysiology of lymphatic circulation in different disease conditions 166
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 165
Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience. 165
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 165
Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue. 165
2015 ESC Guidelines for the management of infective endocarditis 165
PET/MRI in Infection and Inflammation 164
Tissue imaging of (111)in-oxine labeled human endothelial progenitor cells in muscle ischemia and inflammation 163
Radiopharmaceuticals for Radioguided Surgery 163
Other Imaging Modalities in Infective Endocarditis Diagnosis 162
Role of positron emission tomography in diagnosis and follow-up of pancreatic lesions 160
Body Mass Index and Body Composition in Adolescents Treated with Gonadotropin-Releasing Hormone Analogue Triptorelin Depot for Central Precocious Puberty: Data at Near Final Height 159
18-FDG PET for large vessel vasculitis diagnosis and follow-up 159
Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. 157
Differentiated thyroid cancer: A new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients 157
PET/CT and PET/MRI in Neurology: Infection/Inflammation 155
Diagnostic performances of [18f]fluorocholine positron emission tomography in brain tumors 155
Radiosynthesis of 68Ga-labelled DOTA-biocytin (68Ga-r-BHD) and assessment of its pharmaceutical quality for clinical use. 154
A pilot clinical trial on scintimammography (SMM) with 99mTc-D-Glucaric Acid in patients with breast cancer 153
Peripheral dual-phase bicompartmental lymphoscintigraphy to localize the site of lymphatic obstruction and guide therapeutic management of patients 153
ASSESSMENT OF TISSUE DISTRIBUTION OF HUMAN ENDOTHELIAL PROGENITOR CELLS BY RADIOACTIVE LABELING IN A MODEL OF HINDLIMB ISCHEMIA 153
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 152
Altre tecniche diagnostiche 152
Methodological Aspects of Lymphoscintigraphy: Radiopharmaceuticals and Instrumentation 152
Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient 152
Differential diagnosis of dementia with Lewy Bodies and Alzheimer’s disease by scintigraphic evaluaton of dopaminergic degeneration and selective regional cerebral blood flow impairment 151
Selective homing of radioactive labeled endothelial progenitor cells in ischaemic hindlimbs 151
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients 151
Preliminary experience with somatostatin receptor scintigraphy for neuroedocrine characterization of patients with hormone-refractory prostatic cancer 150
[18F]FDG-PET/CT evaluation of adrenal lesions in patients with non-small-cell lung cancer 150
Nuclear Medicine Imaging and Cardiotoxicity 150
Tecniche diagnostiche per lo studio del sistema linfatico 149
Multi-dimensional scaling analysis of key regulatory genes in prostate cancer using the tcga database 149
99mTc-Sestamibi Scintigraphy to Monitor the Long-Term Efficacy of Enzyme Replacement Therapy on Bone Marrow Infiltration in Patients with Gaucher Disease. 148
Comparative Diagnostic Accuracy of Whole-Body [18 F]FDG-PET and 99mTc-MDP Bone Scintigraphy in the Identification of Bone Metastasis 147
Scintimammography with 99mTc-D-Glucaric acid in patients with breast cancer: preliminary results 147
Tecniche diagnostiche per lo studio dell’apparato osteo-articolare 147
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT imaging in the characterization and management of patients with infectious endocarditis 147
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 147
Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma 144
Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? 142
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients 142
TISSUE DISTRIBUTION OF RADIOLABELED HUMAN ENDOTHELIAL PROGENITOR CELLS IN NORMAL MICE AND IN A MODEL OF PERIOPHERAL SKELETAL MUSCLE ISCHEMIA AND INFLAMMATION 141
Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease 140
Evaluation of[F-18] NaF uptake in symptomatic and asymptomatic carotid artery plaques and determination of predictive pattern of vulnerable plaque : preliminary results 140
Comparison of single-step, coated-tube assay to a reference Liso-phase method for measuring free triiodothyronine in serum 139
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients 139
Multidrug resistance in cancer: Its mechanism and its modulation 139
Nonorthopedic or Cardiovascular Implantable Device Infection 138
In-vitro Study for Cerenkov Luminescence Imaging Application in Hepatic Metastasectomy 138
Totale 18.400
Categoria #
all - tutte 91.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 0 0 303
2021/20222.581 38 105 107 167 501 370 94 119 170 73 159 678
2022/20232.910 405 449 223 333 263 334 46 209 400 20 172 56
2023/20242.214 281 248 267 172 347 357 83 59 33 34 81 252
2024/20256.661 57 252 102 351 488 536 585 407 669 924 732 1.558
2025/20268.702 525 1.150 1.493 1.118 641 709 1.063 425 483 685 297 113
Totale 32.857